Population pharmacokinetics of cisplatin in adult cancer patients

被引：0
|
作者：
Felix E. de Jongh
James M. Gallo
Meiyu Shen
Jaap Verweij
Alex Sparreboom
机构：
[1] Erasmus MC—Daniel den Hoed Cancer Center,Department of Medical Oncology
[2] Ikazia Hospital,Department of Internal Medicine
[3] Fox Chase Cancer Center,Department of Pharmacology
[4] National Cancer Institute,Clinical Pharmacology Research Core, Medical Oncology Clinical Research Unit
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 54卷
关键词：
Cisplatin; Population model; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：105 / 112
页数：7
相关论文
共 50 条
  • [1] Population pharmacokinetics of cisplatin in adult cancer patients
    de Jongh, FE
    Gallo, JM
    Shen, MY
    Verweij, J
    Sparreboom, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (02) : 105 - 112
  • [2] Population pharmacokinetics of total and unbound plasma cisplatin in adult patients
    Urien, S
    Lokiec, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (06) : 756 - 763
  • [3] Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients
    Yang, Xin-Mei
    Ye, Pan-Pan
    Liu, Xiao-Lin
    Guo, Zi-Xuan
    Kan, Min
    Li, Qian
    Song, Lin-Lin
    Liu, Hong-Ying
    Chen, Ke-Guang
    Shi, Jin-Yi
    Zhang, Ye-Hui
    Li, Ya
    Zhao, Fu-Rong
    van den Anker, John
    Li, Yan
    Zhao, Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (06) : 1862 - 1872
  • [4] Population pharmacokinetics and renal toxicity of cisplatin in cancer patients with renal dysfunction
    Morita-Ogawa, Tomoko
    Sugita, Hiroki
    Minami, Hironobu
    Yamaguchi, Takuhiro
    Hanada, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 559 - 566
  • [5] Population pharmacokinetics and renal toxicity of cisplatin in cancer patients with renal dysfunction
    Tomoko Morita-Ogawa
    Hiroki Sugita
    Hironobu Minami
    Takuhiro Yamaguchi
    Kazuhiko Hanada
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 559 - 566
  • [6] Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: Analysis with the NONMEM program
    Nagai, N
    Ogata, H
    Wada, Y
    Tsujino, D
    Someya, K
    Ohno, T
    Masuhara, K
    Tanaka, Y
    Takahashi, H
    Nagai, H
    Kato, K
    Koshiba, Y
    Igarashi, T
    Yokoyama, A
    Kinameri, K
    Kato, T
    Kurita, Y
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (11): : 1025 - 1034
  • [7] Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients
    Perez-Ruixo, Juan Jose
    Piotrovskij, Vladimir
    Zhang, Steven
    Hayes, Siobhan
    De Porre, Peter
    Zannikos, Peter
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) : 81 - 96
  • [8] Population pharmacokinetics of micafungin in adult patients
    Gumbo, Tawanda
    Hiemenz, John
    Ma, Lei
    Keirns, James J.
    Buell, Donald N.
    Drusano, George L.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (03) : 329 - 331
  • [9] Population pharmacokinetics of ciprofloxacin in adult patients
    Mangin, O.
    Hirt, D.
    Bouazza, N.
    Foissac, F.
    Treluyer, J. M.
    Urien, S.
    Benaboud, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 70 - 71
  • [10] Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy
    Panteix, G
    Beaujard, A
    Garbit, F
    Chaduiron-Faye, C
    Guillaumont, M
    Gilly, F
    Baltassat, P
    Bressolle, F
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1329 - 1336
12345